CASGEVY J Code: J3392

Drug & Product Overview

HCPCS Descriptor Injection, exagamglogene autotemcel, per treatment

HCPCS Added Date January 1, 2025

Manufacturer Vertex Pharmaceuticals

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Form Injection, Suspension

About CASGEVY

Casgevy is a medication aligned to the HCPCS J Code: J3392 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Vertex Pharmaceuticals.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J3392. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	CASGEVY

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

CASGEVY Pricing & Reimbursement

J3392 Private Payer Reimbursement

$5,512.50 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

CASGEVY CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

CASGEVY Medically Unlikely Edits (MUE)

The most billing units of J3392 Medicare will pay for one patient in one day, as published by CMS. 1 unit = per treatment.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

CASGEVY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Sickle cell disease Transfusion-dependent β-thalassemia

Frequently Asked Questions

Is there an available CASGEVY billing and coding guide?

Billing and coding information for CASGEVY can be found through Vertex Pharmaceuticals Incorporated. Visit Here →

What are the available CASGEVY patient assistance programs?

CASGEVY patient assistance information can be found through Vertex Pharmaceuticals Incorporated. Visit Here →

Where can I find CASGEVY prescribing information?

CASGEVY prescribing information can be found at the link below. Visit Here →

Where can I find CASGEVY side effect information?

CASGEVY side effect information can be found through MedlinePlus at the link below.

Does billing CASGEVY require JZ/JW wastage modifiers?

CMS does not include CASGEVY (J3392) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J3392. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.